Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of a Moderate CAlorie and Protein REstriction PROgram (CARE-PRO) as an Efficient and Affordable Therapeutic Strategy in Patients With Barrett's Esophagus.

NCT03813381 is registered in ClinicalTrials.gov with Istituto Oncologico Veneto IRCCS as lead sponsor.

NCT NCT03813381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03813381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of a Moderate CAlorie and Protein REstriction PROgram (CARE-PRO) as an Efficient and Affordable Therapeutic Strategy in Patients With Barrett's Esophagus.
Lead sponsor
Istituto Oncologico Veneto IRCCS
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
December 31, 2021
Enrollment
160 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

barrett's esophagus, overweight and obesity